AQR Capital Management - Q4 2020 holdings

$56.4 Billion is the total value of AQR Capital Management's 2529 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 0.0% .

 Value Shares↓ Weighting
BRKA  BERKSHIRE HATHAWAY INC DELcl a$21,912,000
+8.7%
630.0%0.04%
+14.7%
WLTW  WILLIS TOWERS WATSON PLC LTD$6,224,000
+0.9%
29,5410.0%0.01%
+10.0%
QTWO  Q2 HLDGS INC$1,350,000
+38.7%
10,6670.0%0.00%0.0%
KW  KENNEDY-WILSON HOLDINGS INC$1,168,000
+23.2%
65,2660.0%0.00%0.0%
KDP  KEURIG DR PEPPER INC$885,000
+16.0%
27,6410.0%0.00%
+100.0%
CMRX  CHIMERIX INC$930,000
+94.2%
192,4580.0%0.00%
+100.0%
HSKA  HESKA CORP$385,000
+47.5%
2,6400.0%0.00%
MITK  MITEK SYS INC$736,000
+39.7%
41,3750.0%0.00%0.0%
DCOM  DIME CMNTY BANCSHARES INC$690,000
+39.4%
43,7530.0%0.00%0.0%
SOHU  SOHU COM LTDsponsored ads$490,000
-19.8%
30,7510.0%0.00%0.0%
EBR  CENTRAIS ELETRICAS BRASILEIRsponsored adr$671,000
+26.6%
95,9540.0%0.00%0.0%
TWO  TWO HBRS INVT CORP$312,000
+25.3%
48,9500.0%0.00%
BAK  BRASKEM S Asp adr pfd a$324,000
+20.4%
35,9550.0%0.00%
BRFS  BRF SAsponsored adr$328,000
+28.1%
78,0700.0%0.00%
BTAI  BIOXCEL THERAPEUTICS INC$402,000
+6.6%
8,7020.0%0.00%0.0%
CDMO  AVID BIOSERVICES INC$315,000
+51.4%
27,2860.0%0.00%
ATOM  ATOMERA INC$283,000
+53.8%
17,5670.0%0.00%
MFA  MFA FINL INC$310,000
+45.5%
79,6550.0%0.00%
BRMK  BROADMARK RLTY CAP INC$233,000
+3.6%
22,8650.0%0.00%
CVM  CEL-SCI CORP$236,000
-8.5%
20,2370.0%0.00%
CERS  CERUS CORP$108,000
+10.2%
15,6560.0%0.00%
SPPI  SPECTRUM PHARMACEUTICALS INC$79,000
-16.0%
23,0300.0%0.00%
CLBK  COLUMBIA FINL INC$214,000
+39.9%
13,7450.0%0.00%
ASPU  ASPEN GROUP INC$178,000
-0.6%
16,0270.0%0.00%
ABR  ARBOR REALTY TRUST INC$267,000
+23.6%
18,8020.0%0.00%
AGTC  APPLIED GENETIC TECHNOLOGIES$96,000
-15.8%
23,5510.0%0.00%
EVFM  EVOFEM BIOSCIENCES INC$77,000
+2.7%
31,7430.0%0.00%
PFSW  PFSWEB INC$99,0000.0%14,7600.0%0.00%
PAVM  PAVMED INC$176,000
+18.9%
83,1660.0%0.00%
FMBI  FIRST MIDWEST BANCORP DEL$183,000
+47.6%
11,4950.0%0.00%
LC  LENDINGCLUB CORP$143,000
+123.4%
13,5520.0%0.00%
FBIO  FORTRESS BIOTECH INC$220,000
-21.4%
69,2610.0%0.00%
GERN  GERON CORP$85,000
-8.6%
53,5580.0%0.00%
NYMT  NEW YORK MTG TR INC$249,000
+44.8%
67,5360.0%0.00%
FTI  TECHNIPFMC PLC$162,000
+48.6%
17,2230.0%0.00%
MEIP  MEI PHARMA INC$131,000
-15.5%
49,6180.0%0.00%
NGVC  NATURAL GROCERS BY VITAMIN C$143,000
+40.2%
10,3750.0%0.00%
CTIC  CTI BIOPHARMA CORP$49,000
+48.5%
15,3650.0%0.00%
CDZI  CADIZ INC$116,000
+7.4%
10,8590.0%0.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

About AQR Capital Management

AQR Capital Management is a global investment management firm that was founded in 1998 by Clifford Asness, David Kabiller, John Liew, and Robert Krail. The firm is headquartered in Greenwich, Connecticut, and has additional offices in Chicago, London, Sydney, and Hong Kong. AQR manages over $186 billion in assets for institutional investors, financial advisors, and individual investors.

The firm's investment philosophy is based on the principles of systematic research, diversification, and risk management. AQR's investment strategies include long-only equity, fixed income, and alternative investments such as hedge funds and private equity. The firm's investment process is driven by a team of over 300 researchers and portfolio managers who use quantitative analysis to identify investment opportunities and manage risk.

AQR is led by a team of experienced executives, including CEO David Kabiller, COO Matt Jiannino, and Chief Investment Officer Ronen Israel. The firm has received numerous awards for its investment performance and innovation, including being named "Hedge Fund Manager of the Year" by Institutional Investor in 2014.

Overall, AQR Capital Management is a well-respected investment management firm that has a strong track record of delivering consistent returns for its clients. However, as with any investment, it is important for investors to conduct their own due diligence and consult with a financial advisor before making any investment decisions.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
APPLE INC43Q3 20233.9%
MICROSOFT CORP43Q3 20233.5%
AMAZON COM INC43Q3 20232.8%
JOHNSON & JOHNSON43Q3 20231.3%
TAIWAN SEMICONDUCTOR MFG LTD43Q3 20231.6%
PROCTER & GAMBLE CO43Q3 20231.4%
PFIZER INC43Q3 20231.4%
MERCK & CO INC NEW43Q3 20231.2%
WAL-MART STORES INC43Q3 20231.1%
INTEL CORP43Q3 20231.3%

View AQR Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)

View AQR Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-03-04
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View AQR Capital Management's complete filings history.

Compare quarters

Export AQR Capital Management's holdings